ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 1187

$289K Total Retail Price of All Prescriptions

Rank: 263 out of 1187

380 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oregon
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 331 303 59 1 1
LEVOTHYROXINE SODIUM 292 277 50 2 2
HYDROCHLOROTHIAZIDE 284 279* 55 3 10
ATENOLOL 275 270* 45 4 11
HYDROCODONE-ACETAMINOPHEN 213 208* 53 S3 5 5
ATORVASTATIN CALCIUM 208 186 39 6 8
LOVASTATIN 184 169 32 7 16
AMLODIPINE BESYLATE 183 183 28 8 6
OMEPRAZOLE 171 166* 29 9 4
FUROSEMIDE 165 160* 35 10 9
WARFARIN SODIUM 163 158* 26 11 13
SIMVASTATIN 160 155* 27 12 3
METOPROLOL TARTRATE 136 131* 20 13 15
METFORMIN HCL 136 117 27 13 7
METOPROLOL SUCCINATE 134 134 23 15 18
GABAPENTIN 117 86 14 16 12
POTASSIUM CHLORIDE 111 106* 19 17 17
TAMSULOSIN HCL 111 111 16 17 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 101* 18 19 27
LOSARTAN POTASSIUM 106 101* 21 19 14
ALLOPURINOL 106 101* 15 19 30
PRAVASTATIN SODIUM 104 99* 20 22 19
CITALOPRAM HBR 97 92* 14 23 20
ALENDRONATE SODIUM 96 96 21 24 28
TRAZODONE HCL 88 73 17 25 21
FINASTERIDE 88 88 16 25 92
NIFEDIPINE ER 86 81* 12 27 153
DOXAZOSIN MESYLATE 83 78* 13 28 66
GLIPIZIDE 79 74* 12 29 44
ZOLPIDEM TARTRATE 79 63 22 29 24
TRAMADOL HCL 72 52 15 31 30
PREDNISONE 70 65* 21 32 42
ISOSORBIDE MONONITRATE ER 68 <11 <11 33 89
LOSARTAN-HYDROCHLOROTHIAZIDE 66 <11 <11 34 57
SPIRIVA 65 <11 <11 35 51
DIGOX 62 <11 <11 36 154
ADVAIR DISKUS 61 56* 13 37 38
PAROXETINE HCL 59 54* 12 38 52
FLUOXETINE HCL 59 <11 <11 38 33
RISPERIDONE 57 <11 <11 A 40 80
OXYCODONE HCL 51 37 16 S2 41 22
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.